Abstract: The present invention is directed to a method for inhibiting viral replication and treating viral infections by administering a pharmaceutically effective amount of a compound capable of binding a microtubule such as a diiodo thyronine analogue having no significant hormonal activity. The present invention also features novel pharmaceutical compositions comprising the same.
Abstract: The present invention provides an AAV vector having a foreign DNA coding for a protein that boosts immunogenicity of cells. The invention also provides a vaccine containing such a vector and the use of both.
Type:
Grant
Filed:
May 5, 1999
Date of Patent:
January 9, 2001
Assignee:
Medigene AG
Inventors:
Gerhard Maass, Michael Hallek, Christoph Bogedain
Abstract: The present invention relates to a protein having an anti-tumoral effect, a DNA encoding such a protein, and a process for the preparation of such a protein as well as its use.
Abstract: There is disclosed a surface mount, circular DIN connector (10) with a housing (12) having a mating face (22) and a terminal receiving face (24). Three rows of terminal receiving cavities (1 to 8) open into the mating face (22) and the terminal receiving face (24). A set of electrical terminals (30) each has a mating portion (32) in a respective one of the cavities (1 to 8), a solder tail (36) extending substantially normally of the mating portion (32), and a connecting arm (38) connecting the mating portion (32) to the solder tail (36). The arms (38) are dimensioned relatively to offset the solder tails (36) with respect to the mating portions (32), in interleaved relationship to form a single row of solder tails (36) for soldering to respective contact pads arranged in a single row on a printed circuit board (20).